CG Invites Co Ltd
CG Invites Co Ltd has a market price of 1,166 KRW and a market cap of 89,658,616,212 KRW, with a price-to-book ratio of 0.85 and a price-to-tangible-book ratio of 0.85. The company's liquidity position is characterized by a current ratio of 0.51 and a negative free cash flow of -13,896,914,440 KRW, indicating a medium liquidity risk. The company's debt-to-equity ratio is 0.78, with long-term debt of 82,518,052,690 KRW and total equity of 105,152,742,370 KRW. The company's profitability is negative, with a return on equity of -3.35% and a return on assets of -1.57%. The operating income is -23,746,367,760 KRW, and the net income is -3,520,966,900 KRW. These figures are below the industry median for profitability metrics, indicating a weak performance relative to its peers. CG Invites Co Ltd's revenue is concentrated across three segments: Pharmaceutical Research and Development, Pharmaceutical Manufacturing, and Other. The company's revenue is not disclosed by segment, but the Other segment includes the manufacture and sale of hot packs and other household items. The company's geographic exposure is primarily in Korea, with no significant international operations disclosed. The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. The company's revenue history shows a total revenue of 27,391,445,370 KRW, but the operating cash flow is negative at -17,412,712,040 KRW. The capital expenditure is -7,992,704,100 KRW, indicating a reduction in investment. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flags include a negative net cash position after subtracting total debt. The company's dilution potential is low, with no significant dilution sources identified. Recent events and filings do not provide specific details on the company's recent activities or strategic initiatives. The company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability trends.
Business. CG Invites Co Ltd is a Korea-based company engaged in the development and manufacturing of pharmaceuticals, operating through three segments: Pharmaceutical Research and Development, Pharmaceutical Manufacturing, and Other, which includes the manufacture and sale of hot packs and other household items.
Classification. CG Invites Co Ltd is classified under the Healthcare economic sector, Pharmaceuticals & Medical Research business sector, and Pharmaceuticals industry, with a classification confidence of 0.92.
- CG Invites Co Ltd has a negative net income and operating income, indicating poor profitability.
- The company's liquidity position is weak, with a current ratio of 0.51 and a negative free cash flow.
- The company's debt-to-equity ratio is 0.78, suggesting a moderate level of leverage.
- The company's return on equity and return on assets are negative, indicating poor asset utilization and equity returns.
- The company's revenue is concentrated across three segments, with no significant international operations.
- # RATIONALES
- margin_outlook_rationale: The company's negative operating income and net income suggest a deteriorating margin outlook driven by poor cost control and revenue generation.
- rd_outlook_rationale: The company's R&D activities are likely to remain a cost center given the negative operating income and lack of disclosed R&D revenue.
- Net cash is negative after subtracting total debt.